IL10 and colitis: The AhR antagonist StemRegenin 1 essentially abrogated the ameliorative effect of 5HIAA on colitis, as reflected by body weight, DAI, colon length, serum levels of IL‐22 and IL‐10, and colon histology (Figure 5C–H).